Skip to main content
BD Market Insights Logo
Pharmaceuticals & Healthcare Verified Business Profile

Renata Limited

Exchange Ticker: DSE: RENATA

Publicly listed research-driven pharmaceutical and animal health manufacturer, US FDA approved facility exporter, and DSE blue-chip.

Visit Official Website
Headquarters
Plot 1, Milk Vita Road, Section-7, Mirpur, Dhaka, Bangladesh
Primary Sector
Pharmaceuticals & Healthcare
Established
1972
Editorial Status
Verified Documented

Manufactured Products & Services

US FDA Approved Formulations Oral Solid Dosage & Potent Hormones Veterinary Antibiotics & Feed Premixes Sterile Injectable Vaccines

Sectors & Client Industries

Regulated Market Pharma Export Animal Health Products DSE Blue-Chip Healthcare

Corporate Overview

Renata Limited (formerly Pfizer Laboratories Bangladesh) is one of the most respected pharmaceutical enterprises in South Asia. Operating FDA-approved manufacturing lines in Rajendrapur and Mirpur, Renata exports complex therapeutics to the United States, United Kingdom, and Australia.

Sources, Data & References

In accordance with BD Market Insights Editorial Standards, all factual claims, market sizes, and corporate data cited in this publication are cross-referenced with official filings, regulatory bodies, and industry documentation.

  1. US FDA Approved Facility Inspection Database — fda.gov (Accessed: September 28, 2026)
  2. Dhaka Stock Exchange RENATA Profile — dsebd.org (Accessed: September 28, 2026)

Entity Verification Policy

BD Market Insights publishes verified corporate profiles derived from public regulatory filings, direct corporate statements, and established industry documentation. We do not accept paid compensation for profile placement or rankings.

Read our selection criteria →